Results 1 to 10 of about 87,208 (292)
Surgery versus chemoradiotherapy in patients with stage T1bN0M0 esophageal cancer: a retrospective cohort study [PDF]
Scientific ReportsTo compare survival outcomes between surgery and chemoradiotherapy in patients with stage T1bN0M0 esophageal cancer. Stage T1bN0M0 esophageal cancer patients treated with either surgery or chemoradiotherapy were extracted from the Surveillance ...
Zu-Yi Chen +5 more
doaj +2 more sources
Chemoradiotherapy versus radiotherapy in patients with stage T1-2N0M0 small cell lung cancer: a retrospective cohort study [PDF]
BMC Pulmonary MedicinePurpose To compare survival outcomes between chemoradiotherapy versus radiotherapy in patients with stage T1-2N0M0 small cell lung cancer (SCLC). Materials and methods SCLC patients from the Surveillance, Epidemiology, and End Results databases between ...
Juan Lin +4 more
doaj +2 more sources
PLoS ONE, 2022 IntroductionThe purpose of the current study is to compare definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with cT1-3/N0-3 esophageal squamous cell carcinoma in survival.MethodsRecords from 2008 to 2014 of 4931 ...
Yi-Lin Chang +8 more
doaj +2 more sources
Frontiers in Neurology, 2022 PurposeBreast cancer (BC) is the highest frequent malignancy in women globally. Approximately 25–60% of BC patients with chronic neuropathic pain (CNP) result from advances in treating BC. Since the CNP mechanism is unclear, the various treatment methods
Rui Liu +7 more
doaj +1 more source
Definitive chemoradiotherapy [PDF]
Journal of Thoracic Disease, 2017 Definitive chemoradiotherapy (dCRT) is reflecting a treatment standard in oesophageal cancer. For irresectable localised tumours and for inoperable patients, dCRT can change the treatment intent from palliative to curative. In patients with squamous cell carcinoma (SCC), in particular in those of cervical location, dCRT is a proper alternative for ...
Stahl, Michael, Budach, Wilfried
openaire +2 more sources
Frontiers in Genetics, 2022 Background: Hepatocellular carcinoma (HCC) is a malignancy with a poor prognosis. This study aimed to distinguish patients with HCC having distinct tumour immune microenvironment (TIME) features and construct an immune-related gene signature (IRGs) to ...
Liangliang Wang +3 more
doaj +1 more source
Clinical Observation of Apatinib in Treatment of Refractory Advanced Breast Cancer
Zhongliu Fangzhi Yanjiu, 2020 Objective To evaluate the clinical efficacy and safety of apatinib in the treatment of advanced breast cancer(ABC) patients refractory to multiline treatments.
WANG Jing +5 more
doaj +1 more source
Identification of prognostic alternative splicing signature in gastric cancer
Archives of Public Health, 2022 Background Aberrant alternative splicing (AS) events could be viewed as prognostic indicators in a large number of malignancies. This study aims to identify prognostic AS events, illuminate the function of the splicing variants biomarkers and provide ...
Zhiwu Wang +4 more
doaj +1 more source
Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer [PDF]
Cochrane Database of Systematic Reviews, 2013 Please see Appendix 4 for a glossary of terms.The outcome of patients with esophageal cancer is generally poor. Although multimodal therapy is standard, there is conflicting evidence regarding the addition of esophagectomy to chemoradiotherapy.To compare the effectiveness and safety of chemoradiotherapy plus surgery with that of chemoradiotherapy alone
Balamurugan A, Vellayappan +5 more
openaire +2 more sources
NIHR Open Research, 2021 Background: Neoadjuvant cancer treatment is associated with improved survival following major oesophagogastric cancer surgery. The impact of neoadjuvant chemo/chemoradiotherapy on physical fitness and operative outcomes is however unclear.
Lisa Loughney +11 more
doaj +1 more source